Nuzenio

Marketbeat Chardan Capital

Marketbeat Chardan Capital entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 11 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Wed, 05 Aug 2026 22:27:04 GMTChardan Capital Reiterates "Buy" Rating for TeraWulf (NASDAQ:WULF) - MarketBeat
Wed, 05 Aug 2026 16:53:36 GMTGalaxy Digital (NASDAQ:GLXY) Receives "Buy" Rating from Chardan Capital - MarketBeat
Tue, 04 Aug 2026 12:50:20 GMTChardan Capital Reiterates Buy Rating for Stoke Therapeutics (NASDAQ:STOK) - MarketBeat
Tue, 04 Aug 2026 12:50:14 GMTChardan Capital Reaffirms "Buy" Rating for Cipher Mining (NASDAQ:CIFR) - MarketBeat
Fri, 31 Jul 2026 12:16:05 GMTAlnylam Pharmaceuticals (NASDAQ:ALNY) Given "Buy" Rating at Chardan Capital - MarketBeat
Fri, 31 Jul 2026 11:09:02 GMT4D Molecular Therapeutics (NASDAQ:FDMT) Rating Increased to Strong-Buy at Chardan Capital - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Marketbeat Chardan Capital.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.